Department of PsychiatryAt PCRP, psychosis is treated like any other medical condition, with compassion, specialized expertise and multi-disciplinary care and innovation.
The Psychosis Clinical and Research Program (PCRP), co-led by Drs. Oliver Freudenreich and Daphne Holt, seeks to improve quality of life for people with psychosis or schizophrenia by reducing distressing symptoms, improving function in school, work and relationships, and promoting better physical health.
Our team of clinicians and researchers conducts state-of-the-art research focused on medication intervention trials, neuroscience and brain imaging, genetics and psychosocial interventions. We offer comprehensive diagnostic evaluations, second-opinion consultations, a clozapine clinic and ongoing treatment for adolescent and adult patients with psychosis, including schizophrenia and related disorders.
Five specialized services support people across different stages and treatment needs. Select a service to learn more or begin a referral.
Evaluation and recommendations for young people experiencing changes that may indicate risk for psychosis or another neuropsychiatric condition.
Coordinated evaluation, treatment and recovery support for adolescents and adults experiencing psychosis for the first time.
Ongoing psychiatric medication care and group therapy for adults living with an established psychotic illness.
Specialized evaluation and medication management for adults taking clozapine or considering a clozapine trial.
Patients and, when appropriate, family members meet with specialists for a one-time evaluation and recommendations. Recommendations are also communicated to the referring clinician.
All referrals are screened for clinical appropriateness. Submitting a referral is not a guarantee of treatment. Patient and family consultation requests must be discussed with the current treating clinician.
World-class researchers and caregivers work together to deepen our understanding of risk factors for psychosis, the full course of schizophrenia and related disorders, and to translate that understanding into compassionate, effective treatment. What makes our team unique is that many of our researchers are also clinicians who see patients.
The Psychosis Clinical & Research Program includes expert clinicians who offer comprehensive diagnostic evaluations, second-opinion consultations and ongoing treatment for patients with schizophrenia and related disorders.
Co-Director, Psychosis Clinical and Research Program
Director, TRS ACCESS Network
Professor of Clinical Psychiatry, Harvard Medical School
Co-Director, Psychosis Clinical and Research Program
Professor of Psychiatry, Harvard Medical School
Director, Acute Psychiatry Service
Director of Clinical Services, PCRP
Assistant Professor of Psychiatry, Harvard Medical School
Director, Center of Excellence for Psychosocial and Systemic Research
Associate Professor of Psychology, Harvard Medical School
Co-Director, Mass General Neuroscience
Director, Early Brain Development Initiative
Associate Professor of Psychiatry, Harvard Medical School
Baktash Babadi, MD, PhD
Jacqueline Clauss, MD, PhD
Drew Coman, PhD
Nicole DeTore, PhD
Hamdi Eryilmaz, PhD
A. Eden Evins, MD, MPH
Cheryl Foo, PhD
Victoria Hasler, PhD
Marta Hernandez
Kelly Irwin, MD
Gina Kuperberg, MD, PhD
Carol Lim, MD, MPH
Thomas Damario
Dara Manoach, PhD
Sarah MacLaurin, PMHNP
Dimitrios Mylonas, PhD
Leah Namey
Elaine Shen, MD
Temitope Ogundare, MD
Shreedhar Paudel, MD, MPH
Katelyn Ragone
Faith Scanlon, PhD
John Tyson, MD
Lauren Utter, PsyD
Louis Vinke, PhD
Alexandra Volpacchio, PsyD
Schizophrenia and psychosis are serious, but also misunderstood, conditions. If you think a loved one is dealing with psychosis, it is vital to get help in the early stages of illness. Begin by learning more about schizophrenia and other forms of psychosis.
View our resources ›Families are our highest priority. We partner with patients to provide high-quality specialty care tailored to each family’s preferences and needs. Your support helps us expand care, education and research.
Give today ›